Cardiac Sodium Channel Dysfunction and Dilated Cardiomyopathy: A Contemporary Reappraisal of Pathophysiological...

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Identifying specific causes of arrhythmias and heart failure is crucial for targeted interventions.
• Pathogenic variants in the cardiac sodium channel gene (SCN5A) are associated with diverse electrical and structural phenotypes, including dilated cardiomyopathy.

Purpose of the Study:

• To critically appraise the evidence linking SCN5A dysfunction to ventricular dysfunction.
• To discuss potential mechanisms underlying the SCN5A-associated phenotype.
• To explore implications for precision therapy in cardiovascular medicine.

Main Methods:

• Literature review and critical appraisal of experimental and medical data.
• Analysis of studies investigating SCN5A variants and their associated phenotypes.
• Synthesis of evidence regarding the role of cardiac sodium channel dysfunction in dilated cardiomyopathy.

Main Results:

• SCN5A variants can lead to a spectrum of cardiac abnormalities, with a notable association with dilated cardiomyopathy.
• Debate exists on whether left ventricular remodeling is a direct consequence of SCN5A dysfunction or secondary to arrhythmias.
• Emerging evidence suggests a complex interplay between channel function, electrical disturbances, and structural remodeling.

Conclusions:

• A dysfunctional cardiac sodium channel is linked to ventricular dysfunction, contributing to dilated cardiomyopathy.
• Understanding the mechanisms of SCN5A-related phenotypes is essential for developing effective precision therapies.
• Further research is needed to fully elucidate the causal relationship and guide clinical management.